Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis

por Goadsby, Peter J, Dodick, David W, Martinez, James M, Ferguson, Margaret B, Oakes, Tina M, Zhang, Qi, Skljarevski, Vladimir, Aurora, Sheena K
Publicado 2019

TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease

por Salloway, Stephen, Lee, Elly, Papka, Michelle, Pain, Andrew, Oru, Ena, Ferguson, Margaret B., Wang, Hong, Case, Michael, Lu, Ming, Collins, Emily C, Brooks, Dawn A., Sims, John
Publicado 2023

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

por Martinez, James M, Ferguson, Margaret B, Pangallo, Beth A, Oakes, Tina M, Sparks, JonDavid, Dellva, Mary Anne, Zhang, Qi, Liu, Peng, Bangs, Mark, Ahl, Jonna, Goldberger, Celine
Publicado 2015